Xplico was established in 2005 with the purpose to develop and market an easy-to-use and standardized tool for valuation of projects and portfolios in the life science industry. Xplico is today the market leader in valuation, supporting more than 100 life science companies in EU, US and Asia on a daily basis.

Currently, Xplico markets three solutions:

Xplico Evaluator is an easy-to-use, flexible valuation tool with integrated risk assessment and powerful analysis features for the life science industry.

Xplico CapTable is an easy-to-use standardized Excel-based tool which is built and tailored to keeping accurate track of multiple ownership and exit scenarios.

Consulting services. We have extensive experience in valuation, forecasting and project/portfolio management and our team of consultants can evaluate your projects and/or company or support you during partnering negotiations.

News from the Xplico world



BIO EUROPE SPRING, Milan, Italy, March 17-19, 2025.

BIO-Europe is the gateway to the global biopharma community and celebrates 30 years of facilitating partnerships. The conference convenes over 5,500 attendees, representing 60 countries and 2,800+ companies, making the event the industry's largest gathering of biopharma professionals in Europe.

(January 2025)


LSX World Congress, London, UK, April 28-30, 2025.

The LSX World Congress is the leading partnering, strategy and investment event in Europe, with qualified 1:1 partnering at its core.

The event brings together the CEOs and senior decision makers from the world’s most innovative biopharma, medtech and healthtech companies with investors, senior BD&L teams, R&D leaders and industry KOLs. Together, they share best practice, forge partnerships and investments – all geared at putting capital and ideas to work to help create the world’s future medicines and improve patient outcomes.


LSX Nordic Congress, Bergen, Norway, May 20-21, 2025.

The LSX Nordic Congress connects life science and healthcare industry leaders with international investment and strategic partners to further the growth, development and internationalisation of Nordic & Baltic life science and healthcare innovation.

The mission is to facilitate ever greater international investment into the region, as well as foster strategic partnerships and collaboration with key international healthcare stakeholders.

(January 2025)


BIO International Convention, Boston, USA, June 16-19, 2025.

The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.

Whether you work at a public pharmaceutical company, biotech startup, academia, non-profits, and government or are a researcher, business development professional or investor, BIO is where you'll make valuable connections and build relationships. The proprietary BIO One-on-One Partnering™ match-making platform—included in the Premier Access registration package—allows you to find potential partners, schedule and accept meetings.

(January 2025)